HCPCS code C1771 – Urinary incontinence sling graft repair device

Key takeaways

C1771 reports the sling graft device itself, while the sling operation is reported separately with CPT 57288.

The code is active for 2026 and applies in ambulatory surgery centers and hospital outpatient departments, never on inpatient claims.

An operative note that does not name the device and a weak diagnosis pairing are the two most common reasons C1771 claims are denied.

C2631 covers the same repair device without a sling graft, so the graft language in the operative note decides between the two codes.

Pass-through status changes each calendar year, so confirm it against the current OPPS addendum before every device line goes out.

HCPCS code C1771: Official descriptor and code details

HCPCS code C1771 is the billing code for a urinary incontinence repair device that includes a sling graft. It applies when the graft is supplied and implanted in an ambulatory surgery center (ASC) or a hospital outpatient department (HOPD).

The code belongs to the C-series of HCPCS Level II, which CMS maintains for outpatient devices, drugs, and supplies. These are items a CPT code does not capture on its own.

C-series codes like C1771 were introduced to allow separate device pass-through payments in outpatient settings. Pass-through status carries an expiry date, and CMS updates the list every year. Check the current OPPS Addendum B to see whether C1771 is paid separately or packaged into the APC payment.

Clinical procedure: Urinary incontinence repair with a sling graft

A sling procedure for stress urinary incontinence (SUI) places a narrow strip of material, the graft, beneath the urethra or bladder neck. It restores support lost to pelvic floor weakness. The graft acts as a hammock.

When abdominal pressure rises during coughing, sneezing, or exertion, the sling supports the urethra and prevents leakage. A practice billing this procedure needs both the surgical CPT code and the device HCPCS code on the same encounter.

The sling graft material may be synthetic mesh, autologous fascia (harvested from the patient’s own tissue), or processed allograft. Each material type remains within the C1771 descriptor provided it functions as the sling component of a urinary incontinence repair. The device is implanted during the same session as the sling operation itself.

• Patient population: Predominantly female patients with stress urinary incontinence or mixed incontinence with a stress component
• Procedure setting: ASC or hospital outpatient department under general, spinal, or local anesthesia
• Device role: The sling graft is the implantable component; the surgeon’s work is captured under CPT 57288
• Why separately reportable: The device cost is distinct from the professional and facility service fees and may trigger separate payment in outpatient settings

When to use C1771: Covered indications and appropriate settings

C1771 applies when a sling graft device is furnished in an ASC or HOPD during a urinary incontinence repair procedure. It does not apply in inpatient hospital settings, where the device cost is bundled into the DRG payment rather than reported separately.

Billing C1771 on an inpatient claim is one of the most common setting-related denial triggers. The two checks below decide whether the device line belongs on the claim at all.

ICD-10 diagnosis codes that support C1771

Medical necessity for C1771 is established through the primary diagnosis code. The ICD-10 codes below are the most commonly accepted diagnoses. Criteria vary by region, so check the Local Coverage Determination (LCD) from your Medicare Administrative Contractor (MAC).

C1771 vs. CPT code 57288: Understanding the difference

CPT code 57288 describes the sling operation itself: the surgeon’s incision, graft placement, urethra support creation, and closure. C1771 describes the physical device used during that operation. Both codes may appear on the same ASC claim. One reports the work and the other reports the implant, so neither can stand in for the other.

Reporting CPT 57288 without C1771 can forfeit separate device payment where the payer allows pass-through or device reimbursement. Conversely, reporting C1771 without 57288 will typically result in a denial for missing the primary procedure code.

C1771 vs. C1713 and C2631: Telling similar device codes apart

C1713 is the HCPCS code for an anchor or screw used in bone-to-bone or soft-tissue-to-bone fixation. It belongs to orthopedic and musculoskeletal procedures, not urinary incontinence repair. Both codes sit in the same C-series range and look alike at a glance. That makes them easy to transpose during manual entry.

Submitting C1713 on a urology claim draws an immediate denial. The payer’s clinical edits will not match an orthopedic bone anchor to an incontinence diagnosis. Practices that bill both specialties should add a code-verification step before submission.

The closer neighbor is C2631, repair device, urinary, incontinence, without sling graft. It describes the same device category with no graft implanted. If the operative note documents a sling graft, C1771 is correct. If it documents a repair device alone, the claim needs C2631.

Medicare reimbursement and fee schedule for HCPCS code C1771

Medicare reimburses C1771 under the Hospital Outpatient Prospective Payment System (OPPS) for HOPD claims and under the ASC payment system for ASC facility claims. Current rates come from the annual OPPS Addendum B and the CMS fee schedule lookup tool.

CMS publishes the addendum each November for the following calendar year. C-series rates change annually and pass-through status expires, so the list below describes how payment works rather than a dollar amount. Confirm the current addendum before billing.

• Pass-through payment: If C1771 holds active pass-through status, Medicare pays the device cost separately from the APC. That offsets part of the facility’s acquisition cost.
• Packaged payment: Once pass-through status expires, the device cost is bundled into the APC for the primary surgical service. No separate device line is paid.
• ASC payment: Device-intensive procedures may carry an adjusted ASC rate. Check whether a device offset applies to C1771 in the current year.
• Commercial payers: Rates are negotiated separately and may differ widely from Medicare. Some payers follow OPPS logic, while others apply their own fee schedules.

Effective revenue cycle management for C1771 requires tracking whether pass-through status is active at the time of service, not at the time of coding. A procedure performed in December may be paid as pass-through. If the new year’s OPPS rule drops the code from the list, January claims are packaged instead.

Bundling rules and NCCI edits for C1771

The National Correct Coding Initiative (NCCI) publishes bundling edits that determine which code pairs may be billed together. ASC coders reporting C1771 alongside CPT procedure codes need to know how those edits apply to a device line.

C1771 is a device and supply code, so it does not trigger the procedure-to-procedure edit pairs that two competing CPT codes would. Bundling can still affect it in two ways:

• The primary CPT code may be bundled into a more comprehensive procedure, which leaves C1771 without a payable companion.
• Payer-specific packaging rules may fold the device into the facility APC payment, so no separate device line is paid.

Modifier requirements when billing C1771

Modifiers on HCPCS device codes serve a different purpose than on CPT procedure codes. For C1771, the most relevant modifier scenarios are:

• No modifier: C1771 usually needs none when it is billed as a device line alongside CPT 57288 in an outpatient setting.
• Modifier -59 (or an X-modifier): It may be needed when a separate, distinct service could otherwise be bundled. It attaches to the companion CPT code, not to C1771.
• Modifier -GK means a reasonable and necessary item or service associated with a GA or GZ modifier. It cannot be billed alone and must accompany GA or GZ.
• Modifier -GZ signals an item or service expected to be denied as not reasonable and necessary. Use it only when the practice has judged the service not medically necessary, because it gives up payment.

Verify current modifier applicability against the CMS NCCI Policy Manual for Medicare Services, updated quarterly, before assuming a prior-year modifier strategy is still valid.

Prior authorization requirements for C1771

Traditional Medicare (Parts A and B) does not currently require prior authorization for C1771 as a standalone device code. Medicare Advantage plans set their own policies, and checking them is part of medical billing compliance.

A Medicare Advantage plan may require prior authorization for the sling procedure (CPT 57288) or for the device (C1771) even when traditional Medicare does not. Check the specific plan’s authorization list before scheduling the procedure.

For commercial payers, prior authorization requirements vary by plan and state. When authorization is required, the documentation typically needed includes:

• Confirmed diagnosis of stress urinary incontinence with ICD-10 code (most commonly N39.3)
• Documentation that conservative treatments have been attempted and failed (pelvic floor physical therapy, bladder training, or pharmacologic management)
• Physician attestation confirming the planned procedure and device type
• Relevant diagnostic workup results (urodynamic studies, cystoscopy findings where applicable)

Documentation requirements for C1771 claims

Insufficient documentation is the most common root cause of C1771 denials. Usually the operative note does not identify the sling graft that was used. A note may describe the procedure clinically but never name the device or record its unique device identifier (UDI).

That gives the payer grounds to deny separate payment. A clean claim submission for C1771 needs the following in the record before the claim goes out.

• Operative report: Must name the specific sling graft device (manufacturer and product name), confirm it was implanted during the encounter, and document the anatomical placement
• Device label or UDI: The FDA unique device identifier from the packaging should be attached to the operative note or recorded in the implant log
• Diagnosis confirmation: The primary ICD-10 code (preferably N39.3) must match the clinical narrative. A code the note does not support leaves medical necessity unproven.
• Conservative treatment history: Record of prior non-surgical management, particularly for payers whose LCD requires documented treatment failure before surgery
• Facility charge capture: The device must appear in the facility’s chargemaster as a separately captured implant. Without that entry, the HCPCS line item cannot be generated.

Common claim denial reasons for C1771 and how to avoid them

C1771 denials follow predictable patterns. A denial management workflow sorts rejections by root cause. That lets you fix the process instead of appealing each denial as a one-off.

The denial code on the remittance advice usually points to one of these rows, so reading denial codes quickly shortens the fix. An appeal should lead with three documents:

• The operative note that identifies the device
• The UDI from the device label
• The payer policy or LCD language that supports coverage

Resubmitting the same claim without new documentation will not overturn the denial.

How Pabau keeps C1771 device claims clean before submission

The details a C1771 claim depends on often live in different places. The device name sits in a dictated note, the UDI on a packaging label, and the prior authorization in an email thread. Each one has to be found again when the claim is built.

In Pabau, the practice management platform we build, the treatment note, the signed consent and the invoice sit in one patient record. Its error-checking claims management pre-fills each submission with the patient, treatment and insurer details. Background checks catch missing fields, such as membership numbers and authorization codes, before the claim can be sent.

In the US, claims go out through Claim.MD, with real-time eligibility checks and ERA remittance posting. A status dashboard tracks every claim from submitted to paid, so your team sees a rejected device line as soon as it comes back.

Catch device claim errors before submission

Pabau pre-fills each claim from the patient record and flags missing details before it goes out. Your billing team spends less time reworking denied device lines.

Book a demo

Conclusion

Treat C1771 as a documentation code as much as a billing code. Every denial pattern in this guide traces back to the operative note, the care setting or the year’s pass-through list.

The practical move is to make the pre-submission check routine before the next OPPS update lands. It costs a few minutes per claim. Skipping it costs an appeal cycle on a device line that should have paid the first time.

Book a demo to see how Pabau checks each device claim for missing details before it reaches the payer.

Continue your research

Coding the other urinary incontinence implant? HCPCS code C1815 explains how to bill an implantable urinary sphincter prosthesis, the other device reported for urinary incontinence repair.

Was the graft billed as mesh instead of a sling? HCPCS code C1781 covers implantable mesh, so you can see where its descriptor ends and C1771’s begins.

Choosing the diagnosis code for the claim? ICD-10 code R32 explains when unspecified urinary incontinence applies and when a more specific code is needed.

Does the payer want approval before the sling surgery? The prior authorization process walks through a step-by-step workflow for getting approval before the procedure date.

Frequently asked questions